Sex hormone levels and risk of breast cancer with estrogen plus progestin.

Publication Type:

Journal Article


Journal of the National Cancer Institute, Volume 105, Issue 19, p.1496-503 (2013)


2013, Center-Authored Paper, October 2013, Public Health Sciences Division, Specimen Processing Core Facility


Although high endogenous sex hormone levels and estrogen plus progestin (E+P) therapy are associated with increased breast cancer risk, it is unknown whether pretreatment levels of sex hormones modify E+P effect on breast cancer.